Ami Asset Management Corp
Source: SEC Form 13F · as of Mar 2026Ami Asset Management Corp holds 17 biotech & pharma companies tracked by BioSniper, totaling $142.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$142.7M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 59,804 | $55.0M |
| WSTWest Pharmaceutical Services Inc. | 154,401 | $38.7M |
| ZTSZoetis Inc. | 282,369 | $33.4M |
| MMSIMerit Medical Systems Inc. | 21,818 | $1.5M |
| JNJJOHNSON & JOHNSON | 6,033 | $1.5M |
| SRRKScholar Rock Holding Corp | 28,530 | $1.4M |
| MDGLMADRIGAL PHARMACEUTICALS, INC. | 2,613 | $1.4M |
| CGONCG Oncology, Inc. | 20,129 | $1.4M |
| MRKMerck & Co., Inc. | 10,496 | $1.3M |
| ARQTArcutis Biotherapeutics, Inc. | 50,863 | $1.2M |
| KNSAKiniksa Pharmaceuticals International, plc | 21,943 | $1.1M |
| CYTKCYTOKINETICS INC | 14,816 | $977K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 17,012 | $939K |
| VERAVera Therapeutics, Inc. | 21,952 | $883K |
| NUVBNuvation Bio Inc. | 192,427 | $826K |
| MIRMMirum Pharmaceuticals, Inc. | 8,859 | $818K |
| HALOHALOZYME THERAPEUTICS, INC. | 8,197 | $530K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.